window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • Artificial Intelligence,Biotech,Drug Development,Partnerships & Funding,Research & Development,Technology and platforms

    Nuclera and leadXpro partner on AI-guided workflow for membrane protein drug discovery

    Nuclera and leadXpro have entered a scientific partnership to develop [...]

    February 17, 2026
  • Artificial Intelligence,Biotech,Central Nervous System,Clinical Development,Drug Development,Immunology,Pharmaceuticals and therapeutics,Technology and platforms

    Insilico Medicine and CMS announce AI-powered drug discovery collaborations in CNS and autoimmune diseases

    Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]

    February 15, 2026
  • Diagnostics,Genomics and sequencing,Research & Development,Technology and platforms

    New England Biolabs launches Monarch Mag Cell-free DNA extraction kit for scalable cfDNA isolation

    New England Biolabs has launched the Monarch Mag Cell-free DNA [...]

    February 15, 2026
  • Drug discovery,Technology and platforms

    QDX opens Gordon Bell-winning EXESS quantum chemistry engine to academic researchers

    QDX has opened external access to EXESS, its GPU-accelerated quantum [...]

    February 11, 2026
  • Clinical Development,Data Management,Digital Health,Movers & Shakers,Technology and platforms

    IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close

    IgniteData has appointed Laura Hilty as chief strategy officer and [...]

    February 11, 2026
  • Biotech,Drug Development,Oncology,Research & Development,Technology and platforms

    SPT Labtech and BellBrook Labs unveil high-throughput screening platform targeting VPS4B in cancer research

    SPT Labtech and BellBrook Labs have introduced a miniaturised high-throughput [...]

    February 11, 2026
  • Artificial Intelligence,Data Management,Market Access & Commercialization,Pharmaceuticals and therapeutics,Technology and platforms

    5 Insights on Data Foundations From Top Pharma Leaders

    As the pharmaceutical industry moves from AI experimentation to execution, [...]

    February 10, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Technology and platforms

    Evinova and Bristol Myers Squibb collaborate on AI-driven clinical trial optimisation

    Evinova and Bristol Myers Squibb have entered a strategic collaboration [...]

    February 9, 2026
  • Manufacturing,Packaging,Sustainability,Technology and platforms

    ACG Packaging Materials joins World Economic Forum Global Lighthouse Network as first pharma packaging company

    ACG Packaging Materials has joined the World Economic Forum’s Global [...]

    February 9, 2026
  • CDMOs & Manufacturing,Clinical Trials,Data Management,Technology and platforms

    PSI launches AI platform to improve clinical trial site selection and enrolment

    PSI CRO has launched SYNETIC, an AI-powered semantic knowledge platform [...]

    February 2, 2026
Previous345Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Obesity, Pharmaceuticals and therapeutics, Research & Development
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top